Floatz logo

17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE

Non-malignant Pain

Mundipharma Research GmbH & Co KGSmall moleculePhase 2/3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Non-malignant Pain cohort.

Asset / SponsorPhaseRating
Oxycodone
Mundipharma Research GmbH & Co KG
Phase 2/3B

Same molecule, other indications

17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE is also rated in:

Low Back PainDormant
BBB
Indicative ·
74 / 100
View asset →
PainDormant
BBB
Indicative ·
73 / 100
View asset →
Chronic OsteoarthritisDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →